Alberta Microelectronic Corporation Names New Director of Biomarketing
Edmonton, Alberta, February 17, 2000 - The Alberta Microelectronic Corporation (AMC) has appointed Sandra Katz into the newly created position of Director of Biomarketing. Ms. Katz will be responsible for managing marketing and sales activities, as well as business development plans to expand AMC's business as a biochip supplier.
Ms. Katz has spent sixteen years in biotechnology and related industries, including extensive experience in strategic planning and development, commercialization and promotion. Most recently, she managed her own biopharmaceutical consulting company, Stonewood Biomarketing. Prior to that, she held product and marketing management positions at companies that included Biomira, an Edmonton-based biotechnology company specializing in the development of cancer therapeutics, and Millipore, a multi-national corporation based in Boston, where Ms. Katz managed several key product lines on a world-wide basis in the life science area.
"Sandra brings many years of experience in the areas that are critical for our continued growth'', said Chris Lumb, CEO of AMC. "She offers the right combination of business development expertise and market knowledge and will be an asset as we move forward. We are very pleased to have her on board.''
About Alberta Microelectronic Corporation
AMC - a profitable, growing, private company - designs and fabricates biochips and other microfabricated devices. Biochips are miniaturized components that are enabling radical mprovements in genetic analysis, drug discovery, and medical diagnostics. Through partnerships in place with market-leading instrument manufacturers, AMC is working towards its vision of being a leader in supplying the world market for microfluidics-based biochips.
For further information contact:
Mr. Chris Lumb
President & CEO
Micralyne Inc.
1911 - 94 Street
Edmonton, Alberta
Canada T6N 1E6
Phone: 780-431-4400
clumb@micralyne.com
